Whether healthcare stocks rise under Donald Trump depends on how he carves up Obamacare.
To be sure, something will get done. Trump and the Republican Congress made it clear they would repeal and replace Obamacare if elected.
Assumptions about what Trump will do at first sent pharma stocks soaring and hospital stocks plunging. But the odds are high that Trump's changes won't be as drastic as feared.
Here's what reform will mean for healthcare stocks in 2017...
UnitedHealth Group Inc. (NYSE: UNH) CEO Stephen J. Hemsley unleashed a bombshell of Obamacare news when he announced that his firm is considering a 2017 exit from the exchanges created by the Affordable Care Act.
This devastating Obamacare news confirmed suspicion that the major insurers aren't doing well with their ACA plans.
So what the heck is going on?
Frankly, it's something the ACA's critics have long predicted...
Start the conversation
Leave a Reply
A lot of Baby Boomers are now running smack dab into their retirement.
An aging population coupled with the rising cost of healthcare and prescription drugs is a potent brew for profiting in the healthcare sector.
Let's find out how to take the "Profit Express" right now...
Start the conversation
Leave a Reply
Find out what's ahead for the stock market today.
Get DJIA futures today, stocks to watch, the biggest stock market news, and today's best profit plays.
The Obamacare ruling in the King v. Burwell Supreme Court case is expected this week. It's a decision could impact more than 7.5 million Americans.
Money Morning Chief Investment Strategist Keith Fitz-Gerald has called this decision the "nightmare" scenario for what it could do to citizens and the U.S. economy.
But you don't have to get caught off guard. In fact, you can profit from it
Spending on cancer treatment has been skyrocketing globally. According to the IMS Institute of Health, spending on cancer topped $100 billion globally in 2014. That was a 10% increase from 2013.
That's why many biotech stocks tied to cancer treatments have seen triple-digit gains in the last two years.
Start the conversation
Leave a Reply
Love it or hate it, the Affordable Care Act is one of the single-biggest wealth creation opportunities for the healthcare industry.
And the biggest profits will belong - like they always do - to those who make a "smart entry."
New drug protocols and advancements in medicine are turning the healthcare industry into one of the most profitable sectors out there. And they're not the only game-changers around.
There are other sector "disruptors" waiting to make you a profit.
Here's what you need to look for...
Start the conversation
Leave a Reply
More than a third of Americans have nothing at all saved for retirement. Fortunately, the tech sector provides the kind of returns Americans need to reach their retirement goals.
One of the best ways to build wealth with tech stocks is to focus on those with the potential to double.
Start the conversation
Leave a Reply
The U.S. Supreme Court will be ruling on a crucial Obamacare case in June. This is highlighting a profit opportunity: a quick and dirty play on healthcare stocks.
Today (Wednesday), the high court heard oral arguments in King v. Burwell. The ruling could deliver a deathblow to President Barack Obama's signature Affordable Care Act.
But it's also providing investors with a chance to play healthcare stocks for short-term gains...
In a conversation we had last July, I suggested that despite negative accounts in the mainstream media, healthcare spending was set to rise.
At the time, the unpopularity of the Affordable Care Act made it sound like investing in this area would be dead money for the foreseeable future.
For weeks, investors have been chasing one "Ebola stock" after another, hoping to find the company with a cure for the disease.
But these investors are going about it all wrong. Instead of finding sound investments, they're just chasing headlines.
Start the conversation
Leave a Reply
There are more than 1,000 biotech companies in North America alone. They cover a wide range of sectors including pharmaceuticals, biologics, generics, and medical devices.
But finding the right stocks in such a broad industry is no easy task.
That's why we've targeted the best biotech ETF to buy now. It offers investors an excellent way to play the entire industry, without having to pick a specific sector.
Start the conversation
Leave a Reply
It's a common thought that investing in biotech stocks is just too risky for the average investor - but that's not the case.
It's true that biotechnology stocks can be very volatile - especially when companies have developmental drugs going through clinical trials - so they aren't the right stocks for every investor. But when investors are able to limit risk, they can find their portfolio's biggest profits from biotech.
Money Morning's BioScience Investment Strategist Ernie Tremblay recommends investors use this one simple strategy when investing in biotech.
It helps limit risk and maximize profits. Take a look…
Start the conversation
Leave a Reply
Investing in biotech stocks is risky for those who haven't done enough research. But with just a couple of tips, investors can drastically reduce the risk - and go on to benefit from massive windfalls generated by a company's breakthrough drug development.
To find out the best way to minimize risk in biotech investing, we turned to Money Morning's BioScience Investment Specialist Ernie Tremblay.
According to Tremblay, there are a couple of types of biotech stocks that are especially risky…
For investors looking for the best penny stocks to buy, the biotech sector offers some of the best investment opportunities on the market.
Despite the fact that biotech stocks have been up and down in 2014, Money Morning's Bioscience Investment Specialist Ernie Tremblay sees great profit opportunities for the rest of 2014.
Here are the three best biotech penny stocks to buy now and why they could take off…
Start the conversation